These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20001763)

  • 61. Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins.
    McNally PG; Jowett NI; Kurinczuk JJ; Peck RW; Hearnshaw JR
    Postgrad Med J; 1988 Nov; 64(757):850-3. PubMed ID: 3076667
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Extensive study of human insulin immunoassays: promises and pitfalls for insulin analogue detection and quantification.
    Heurtault B; Reix N; Meyer N; Gasser F; Wendling MJ; Ratomponirina C; Jeandidier N; Sapin R; Agin A
    Clin Chem Lab Med; 2014 Mar; 52(3):355-62. PubMed ID: 24150210
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cromolyn sodium for insulin-induced lipoatrophy: old drug, new use.
    Phua EJ; Lopez X; Ramus J; Goldfine AB
    Diabetes Care; 2013 Dec; 36(12):e204-5. PubMed ID: 24265375
    [No Abstract]   [Full Text] [Related]  

  • 64. Amelioration of insulin lipoatrophy by dexamethasone injection.
    Whitley TH; Lawrence PA; Smith CL
    JAMA; 1976 Feb; 235(8):839-40. PubMed ID: 946314
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Effect of insulin of various degrees of purity on post-insulin lipoatrophy].
    Rogala H; Lawecki J; Czyzyk A
    Pol Arch Med Wewn; 1986 Sep; 76(3):166-71. PubMed ID: 3554162
    [No Abstract]   [Full Text] [Related]  

  • 66. Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports.
    Shibata Y; Nakatsuka A; Eguchi J; Miyamoto S; Masuda Y; Awazawa M; Takaki A; Yoshida R; Yagi T; Wada J
    J Med Case Rep; 2018 Dec; 12(1):368. PubMed ID: 30545408
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of insulin-induced lipoatrophy.
    Hulst SG
    Diabetes; 1976 Nov; 25(11):1052-4. PubMed ID: 992225
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lipoatrophy with human insulin.
    Jaap AJ; Horn HM; Tidman MJ; Walker JD
    Diabetes Care; 1996 Nov; 19(11):1289-90. PubMed ID: 8908398
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Visual Vignette.
    Yang AJ; Magill SB
    Endocr Pract; 2020 Oct; 26(10):1230. PubMed ID: 33471725
    [No Abstract]   [Full Text] [Related]  

  • 70. Lipoatrophy produced in mice and rabbits by a fraction prepared from the urine from patients with congenital generalized lipodystrophy.
    Foss I; Trygstad O
    Acta Endocrinol (Copenh); 1975 Oct; 80(2):398-416. PubMed ID: 1242274
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Localized lipoatrophy due to recombinant growth hormone therapy in a child with 6.7 kilobase gene deletion isolated growth hormone deficiency.
    Büyükgebiz A; Aydin A; Dündar B; Yörükoğlu K
    J Pediatr Endocrinol Metab; 1999; 12(1):95-7. PubMed ID: 10392355
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Insulin lipodystrophy in diabetes mellitus in children].
    Sapelkina LV; Martynova MI; Iankovskaya VN
    Pediatriia; 1971 Jul; 50(7):18-21. PubMed ID: 5137052
    [No Abstract]   [Full Text] [Related]  

  • 73. Relapsing insulin-induced lipoatrophy, cured by prolonged low-dose oral prednisone: a case report.
    Chantelau EA; Praetor R; Praetor J; Poll LW
    Diabetol Metab Syndr; 2011 Dec; 3(1):33. PubMed ID: 22145998
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Non-glycemic Adverse Effects of Insulin.
    Guarneri AM; Hoffman RP
    Curr Diabetes Rev; 2022; 18(2):e012821190877. PubMed ID: 33511950
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multifocal lipoatrophy secondary to insulin injection in a patient with type 2 diabetes, hepatitis B virus infection, and liver cirrhosis.
    Wu Y; Lou X
    J Int Med Res; 2021 Mar; 49(3):300060521990237. PubMed ID: 33682487
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Insulin-resistant diabetes during growth hormone therapy in a child with SHORT syndrome.
    Verge CF; Donaghue KC; Williams PF; Cowell CT; Silink M
    Acta Paediatr; 1994 Jul; 83(7):786-8. PubMed ID: 7949817
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Frequency of lipodystrophy induced by recombinant human insulin.
    Hajheydari Z; Kashi Z; Akha O; Akbarzadeh S
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1196-201. PubMed ID: 22165682
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Lipodystrophy in children and adolescents with diabetes mellitus].
    Tebuev AM
    Pediatriia; 1984 Dec; (12):59-60. PubMed ID: 6395086
    [No Abstract]   [Full Text] [Related]  

  • 79. Lipoatrophy, a rare complication of diabetes: a single-center experience.
    Xatzipsalti M; Alvertis H; Kourousi G; Patouni K; Konstantakopoulos S; Delis D; Vazeou A
    Hormones (Athens); 2022 Mar; 21(1):61-69. PubMed ID: 34671939
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Congenital generalized lipodystrophy].
    Figueiredo Filho PP; Costa Val A; Diamante R; Cunha CF; Norton RC; Lamounier JA; Leão E
    J Pediatr (Rio J); 2004; 80(4):333-6. PubMed ID: 15309237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.